Ohne eingeschaltetes JavaScript können Sie PSIAC nicht in vollem Umfang nutzen.
Literaturverzeichnis
Fachinformation, Juni 2002 [979]
Fachinformation, Juni 2003 [1319]
Fachinformation, Juni 2004 [579]
Fachinformation, Mai 2002 [1922]
Fachinformation, März 1998 [520]
Fachinformation, März 2000 [1383]
Fachinformation, März 2001 [612]
Fachinformation, März 2010 [576]
Fachinformation, Oktober 2001 [2402]
Fachinformation, September 1996 [993]
Fachinformation: Accupro [4132]
Fachinformation: Captopril ABZ [4126]
Fachinformation: Cibacen [4130]
Fachinformation: Dynorm [4131]
Fachinformation: Lisinopril AbZ [4128]
Fachinformation: Ramipril ABZ [4129]
Fachinformation: Udrik [4133]
Fachinformationen 2002 [699]
Fachinformationen 2002 und siehe Metabolit Oxazepam [631]
Fachinformationen Benperidol [682]
Fachinformationen Champix (2006) [2622]
Fachinformationen, 2002 [688]
Fachinformationen, Juni 2002 [1584]
Fachinformationen, März 2003 [712]
Fagiolini A. J Clin Psychopharmacol. Oct 2001; 21(5): 474-8
Pubmed [6954]
Falcão A. Epilepsy Res. Sep 2013; 106(1-2): 244-9
Pubmed [10609]
Falcon RW. Clin Pharmacokinet. Jan 2008; 47(2): 75-89
Pubmed [6292]
Falcón-Chévere JL. Bol Asoc Med P R. Oct 2007; 99(4): 325-30
Pubmed [7646]
Falhammar H. Eur J Intern Med. Jan 2019; 59: 65-69
Pubmed [11193]
Falhammar H. J Psychopharmacol. Feb 2021; 35(2): 184-189
Pubmed [12383]
Fallon RJ. Lancet. Oct 1975; 2(7939): 792-4
Pubmed [6258]
Fallone CA. Gastroenterology. Jul 2019; 157(1): 44-53
Pubmed [7972]
Falloon J. Antimicrob Agents Chemother. Jul 1994; 38(7): 1580-7
Pubmed , Volltext [5247]
Falls BA. Psychosomatics. May 2014; 55(3): 305-9
Pubmed [3060]
Fan L. Ann Pharmacother. May 2009; 43(5): 944-9
Pubmed [11852]
Fan L. Eur J Clin Pharmacol. Apr 2009; 65(4): 403-9
Pubmed [3017]
Fancher KM. Cancer Chemother Pharmacol. Oct 2020; 86(4): 507-515
Pubmed [13888]
Fanelli, Montgomery. Psychopharmacol Bull (1996) 32, 442 [1492]
Fang F. CNS Drugs. Sep 2016; 30(9): 845-67
Pubmed [11065]
Fang J. Adv Ther. Jun 2021; 38(6): 2921-2934
Pubmed [13533]
Fankhauser CD. Semin Oncol Nurs. Aug 2020; 36(4): 151042
Pubmed [10023]
Fann WE et al. Clin Pharmacol Ther (1972) 13, 71-7. Ghose K. Eur J Clin Pharmacol (1980) 17, 233-8 [1737]
Fann WE, Davis JM, Janowski DS, Schmidt D. The effects of antacids on the blood levels of chlorpromazine. Clin Pharmacol Ther (1973) 14, 135 [814]
Fann WE, Janowsky DS, Davis JM, Oates JA. Chlorpromazine reversal of the antihypertensive action of guanethidine. Lancet (1971) ii, 436-7 [868]
Fann WE. J Clin Pharmacol. Oct 1973; 13(10): 388-90
Pubmed [813]
Fanos V. Drug Saf. Mar 1999; 20(3): 245-67
Pubmed [5367]
Fanos V. J Chemother. Oct 2001; 13(5): 461-72
Pubmed [5368]
Fanouriakis A. Ann Rheum Dis. Jun 2019; 78(6): 736-745
Pubmed [8881]
Faraj P. EBioMedicine. Sep 2023; 95: 104779
Pubmed [14111]
Farenc C. J Clin Pharmacol. Jan 2001; 41(1): 44-50
Pubmed [11152]
Farhangi V. Int J Psychiatry Med. Jan 2003; 33(2): 201-2
Pubmed [1749]
Farhat NM. Am J Health Syst Pharm. Jan 2016; 73(2): 56-9
Pubmed [6972]
Farhoudi M. Expert Opin Drug Metab Toxicol. Apr 2015; 11(4): 471-9
Pubmed [8725]
Faria JV. Bioorg Med Chem. Nov 2017; 25(21): 5891-5903
Pubmed [8443]
Fariello RG. Neurotherapeutics. Jan 2007; 4(1): 110-6
Pubmed [12270]
Farlow MR. Clin Pharmacokinet. Jan 2003; 42(15): 1383-92
Pubmed [8003]
Farlow MR. Curr Med Res Opin. Feb 2010; 26(2): 263-9
Pubmed [9933]
Farnier M. Expert Rev Cardiovasc Ther. May 2012; 10(5): 565-75
Pubmed [3958]
Farokhnia M. Psychopharmacology (Berl). Feb 2014; 231(3): 533-42
Pubmed [11517]
Faron-Górecka A. Brain Res. Aug 2004; 1016(2): 263-7
Pubmed [2728]
Farquharson CA. Heart. Nov 2002; 88(5): 475-80
Pubmed [10806]
Farshidi H. Trials. Mar 2025; 26(1): 108
Pubmed [14229]
Faruquee CF. Pak J Pharm Sci. Apr 2010; 23(2): 143-8
Pubmed [5188]
Faskowitz AJ. Cell Mol Neurobiol. May 2013; 33(4): 537-42
Pubmed [12986]
Fattinger K. Eur J Clin Pharmacol. Feb 2002; 57(12): 863-7
Pubmed [11826]
Faucette SR. Drug Metab Dispos. Mar 2004; 32(3): 348-58
Pubmed [425]
Faucette SR. Drug Metab Dispos. Oct 2000; 28(10): 1222-30
Pubmed [67]
Fauchier JP. Arch Mal Coeur Vaiss. May 1993; 86(5 Suppl): 757-67
Pubmed [8804]
Fava M. Int Clin Psychopharmacol. Nov 2018; 33(6): 312-321
Pubmed , Volltext , DOI [10147]
Favale E. Seizure. Jul 2003; 12(5): 316-8
Pubmed [10623]
Fawcett RG. Erythema multiforme major in a patient treated with carbamazepine. J Clin Psychiatry (1887) 48, 416-17 [845]
Fayssoil A. Ann Cardiol Angeiol (Paris). Jun 2011; 60(3): 165-8
Pubmed [3554]
Fazel Y. Expert Opin Drug Saf. Aug 2015; 14(8): 1317-26
Pubmed [6962]
Fazzi P. Am J Respir Med. Jan 2003; 2(4): 311-20
Pubmed [8875]
FDA Stand: 17.02.2016 [25]
Feder A. Am J Psychiatry. Feb 2021; 178(2): 193-202
Pubmed [12416]
Feder. J Clin Psychiatry (1991) 52, 163-164 [1349]
Federico S. Clin Pharmacokinet. Jan 2006; 45(2): 169-75
Pubmed [5671]
Fedgchin M. Int J Neuropsychopharmacol. Oct 2019; 22(10): 616-630
Pubmed [12068]
Fee JPH, et al. Clin Pharmacol Ther (1987) 41, 80-4 [1862]
Feely J. N Engl J Med. Mar 1981; 304(12): 692-5
Pubmed [4152]
Feierman DE. Drug Metab Dispos. Sep 1996; 24(9): 932-9
Pubmed [4702]
Feigenson JS. Neurology. May 1976; 26(5): 430-3
Pubmed [10435]
Feiger AD. CNS Spectr. Jan 2009; 14(1): 41-50
Pubmed [12605]
Feighner JP. J Clin Psychiatry. Jun 1990; 51(6): 222-5
Pubmed [1393]
Fein S. Am J Psychiatry. Feb 1988; 145(2): 249-50
Pubmed [1741]
Feinberg SS. J Clin Psychiatry. Nov 2004; 65(11): 1520-4
Pubmed [2368]
Fekete S. Pharmacopsychiatry. May 2021; 54(3): 117-125
Pubmed [10907]
Feldman et al. J Pharm Clin (1995) 14, 296-297 [1489]
Feldman M. Int J Neurosci. Jun 2021; : 1-12
Pubmed [12193]